<?xml version="1.0" encoding="UTF-8"?>
<item>
    <rel_title>Functional assessment of cell entry and receptor usage for lineage B Î²-coronaviruses, including 2019-nCoV</rel_title>
    <rel_doi>10.1101/2020.01.22.915660</rel_doi>
    <rel_link>http://biorxiv.org/cgi/content/short/2020.01.22.915660</rel_link>
    <rel_abs>Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS- CoV was first identified in animal markets, global viromics projects have discovered thousands of coronavirus sequences in diverse animals and geographic regions. Unfortunately, there are few tools available to functionally test these novel viruses for their ability to infect humans, which has severely hampered efforts to predict the next zoonotic viral outbreak. Here we developed an approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recent 2019-nCoV, for receptor usage and their ability to infect cell types from different species. We show that host protease processing during viral entry is a significant barrier for several lineage B viruses and that bypassing this barrier allows several lineage B viruses to enter human cells through an unknown receptor. We also demonstrate how different lineage B viruses can recombine to gain entry into human cells and confirm that human ACE2 is the receptor for the recently emerging 2019-nCoV.</rel_abs>
    <rel_authors>Letko, M. C.; Munster, V.</rel_authors>
    <rel_date>2020-01-22</rel_date>
    <rel_site>biorxiv</rel_site>
</item>